[Treatment monitoring and innovations in amblyopia treatment].

Therapiemonitoring und Innovationen in der Amblyopietherapie.

Journal

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 26 9 2019
medline: 18 12 2019
entrez: 26 9 2019
Statut: ppublish

Résumé

Technical innovations, such as computer games and shutter glasses open up elegant treatment options for amblyopia. The lack of monitoring of compliance means that there is no scientific basis on which a comparative study between a new therapeutic approach and occlusion therapy as the standard of care could be designed. An easy to use microsensor for measurement of compliance could have a broad spectrum of applications in scientific studies as well as in routine clinical practice. This article gives a brief overview about emerging and innovative approaches.

Identifiants

pubmed: 31552468
doi: 10.1007/s00347-019-00970-0
pii: 10.1007/s00347-019-00970-0
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

1231-1234

Références

J AAPOS. 2016 Aug;20(4):326-31
pubmed: 27418249
Acta Ophthalmol. 2013 Dec;91(8):e635-40
pubmed: 23759025
Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1401-8
pubmed: 19415317
Strabismus. 2006 Jun;14(2):65-70
pubmed: 16760110
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3395-8
pubmed: 20164454
Ophthalmology. 2003 Nov;110(11):2075-87
pubmed: 14597512
JAMA Ophthalmol. 2016 Dec 1;134(12):1391-1400
pubmed: 27812703
Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6158-66
pubmed: 23882695
Klin Monbl Augenheilkd. 2001 Apr;218(4):243-50
pubmed: 11392270
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4393-400
pubmed: 17003431
Strabismus. 2017 Dec;25(4):222-230
pubmed: 29281565
BMJ. 2007 Oct 6;335(7622):707
pubmed: 17855283
Exp Eye Res. 2019 Jun;183:68-75
pubmed: 29758189
Graefes Arch Clin Exp Ophthalmol. 2003 Mar;241(3):176-80
pubmed: 12644939
Vision Res. 2015 Sep;114:4-16
pubmed: 25906685
J AAPOS. 2019 Aug;23(4):205.e1-205.e5
pubmed: 31271842
Strabismus. 2008;16(4):149-58
pubmed: 19089760
Vision Res. 2015 Sep;114:173-87
pubmed: 25917239
Strabismus. 1999 Jun;7(2):113-23
pubmed: 10420216
Optom Vis Sci. 2018 Jun;95(6):523-535
pubmed: 29787486
JAMA Ophthalmol. 2016 Dec 1;134(12):1402-1408
pubmed: 27832248
BMJ Case Rep. 2011 Feb 23;2011:null
pubmed: 22707543
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1435-9
pubmed: 15790912
Ophthalmology. 2009 Feb;116(2):191-9
pubmed: 19084273
Ophthalmology. 2013 Nov;120(11):2270-7
pubmed: 23755872
J AAPOS. 2015 Dec;19(6):552-4
pubmed: 26691037
Dtsch Arztebl Int. 2015 May 8;112(19):338-44
pubmed: 26043421
JAMA Ophthalmol. 2018 Feb 1;136(2):172-181
pubmed: 29302694
J AAPOS. 2015 Jun;19(3):257-9
pubmed: 26059673
Vision Res. 2014 Oct;103:11-9
pubmed: 25130409
Prog Retin Eye Res. 2013 Mar;33:67-84
pubmed: 23201436
Philos Trans R Soc Lond B Biol Sci. 2016 Jun 19;371(1697):
pubmed: 27269607
JAMA Ophthalmol. 2015 May;133(5):606-9
pubmed: 25695355
Vis Neurosci. 2018 Jan;35:E012
pubmed: 29905124
Klin Monbl Augenheilkd. 2010 Oct;227(10):774-81
pubmed: 20963679
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2589-94
pubmed: 17525188
Klin Monbl Augenheilkd. 2012 Oct;229(10):979-86
pubmed: 23096142
PLoS Biol. 2011 Aug;9(8):e1001135
pubmed: 21912514
Acta Ophthalmol. 2016 Dec;94(8):e753-e756
pubmed: 27350046
Arch Ophthalmol. 2007 Apr;125(4):580-1
pubmed: 17420393
JAMA Ophthalmol. 2016 Dec 1;134(12):1347-1353
pubmed: 27737444
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E733-41
pubmed: 21896742
Invest Ophthalmol Vis Sci. 2014 Apr 15;55(4):2384-91
pubmed: 24508791
Am J Ophthalmol. 2006 Jan;141(1):175-184
pubmed: 16386994

Auteurs

Kai Januschowski (K)

Augenklinik Sulzbach, Knappschaftsklinikum Sulzbach/Saar, An der Klinik 10, 66280, Sulzbach, Deutschland. Kai.januschowski@med.uni-tuebingen.de.
Department für Augenheilkunde, Universitätsaugenklinik Tübingen, Schleichstr. 12, 72076, Tübingen, Deutschland. Kai.januschowski@med.uni-tuebingen.de.
Klaus Heimann Eye Research Institute (KHERI), An der Klinik 10, 66280, Sulzbach/Saar, Deutschland. Kai.januschowski@med.uni-tuebingen.de.

Caroline Emmerich (C)

Augenklinik Sulzbach, Knappschaftsklinikum Sulzbach/Saar, An der Klinik 10, 66280, Sulzbach, Deutschland.

Annegret Abaza (A)

Department für Augenheilkunde, Universitätsaugenklinik Tübingen, Schleichstr. 12, 72076, Tübingen, Deutschland.

Henrike Julich-Haertel (H)

Augenklinik Sulzbach, Knappschaftsklinikum Sulzbach/Saar, An der Klinik 10, 66280, Sulzbach, Deutschland.

Annekatrin Rickmann (A)

Augenklinik Sulzbach, Knappschaftsklinikum Sulzbach/Saar, An der Klinik 10, 66280, Sulzbach, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH